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Abstract 
To improve the application of essential oils as natural antimicrobial preservatives, 
the objective of the present study was to determine physical, antimicrobial, and bio-
physical properties of eugenol after nanoencapsulation by sodium caseinate (Na-
Cas). Emulsions were prepared by mixing eugenol in 20.0 mg/mL NaCas solution at 
an overall eugenol content of 5.0–137.9 mg/mL using shear homogenization. Sta-
ble emulsions were observed up to 38.5 mg/mL eugenol, which had droplet diam-
eters of smaller than 125 nm at pH 5–9 after ambient storage for up to 30 days. 
The encapsulated eugenol had similar minimal inhibitory and minimal bactericidal 
concentrations as free eugenol against Escherichia coli O157:H7 ATCC 43895, Liste-
ria monocytogenes Scott A, and Salmonella Enteritidis but showed better inhibition 
of E. coli O157:H7 than free eugenol during incubation at 37 °C for 48 h. After 20 
min interaction at 21 °C, bacteria treated with encapsulated eugenol had a greater 
reduction of intracellular ATP and a greater increase of extracellular ATP than free 
eugenol, suggesting the enhanced permeation of eugenol after nanoencapsula-
tion. However, such overall trend was not observed when examining bacterial mor-
phology and uptake of crystal violet, suggesting the possible membrane adapta-
tion. Findings from this study showed the feasibility of preparing nanoemulsions 
with high loading of eugenol using NaCas. 
Keywords: eugenol, sodium caseinate, nanoemulsion, antimicrobial activity, 
membrane permeability 
Introduction 
Essential oils (EOs) are secondary metabolites of plants [1]. Many EOs and 
their components have excellent antimicrobial activities and can potentially 
be used as natural preservatives to meet the increasing consumer demand 
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for clean labels [1]. However, poor solubility and high volatility of EOs limit 
their application in aqueous foods and beverages. This has led to studies of 
delivery systems to improve their applicability in food matrices. Emulsions 
[2], food biopolymer particles [3, 4], and liposomes [5] are several groups of 
colloidal systems studied to encapsulate EOs. In addition to improving the 
dispersibility of EOs [6, 7], some studies have reported the improved anti-
microbial activity of EOs after encapsulation [5]. Conversely, other studies 
have shown negative effects on antimicrobial activity after encapsulating 
EOs, which would nullify their practical applications [2, 8, 9]. Therefore, ma-
terials used to deliver EOs are to be carefully studied. 
For food applications, delivery systems should ideally be fabricated from 
generally-recognized-as-safe (GRAS) ingredients. To prepare emulsions, 
dairy proteins are extensively studied as natural emulsifiers due to their 
abundance, low cost, and amphiphilic properties. Sodium caseinate (NaCas) 
is a commercially available ingredient that can be used to prepare emulsions 
due to its excellent surface activity. The self-assembly properties of caseins 
have been used to nanoencapsulate hydrophobic molecules such as bixin 
and curcumin [10, 11]. NaCas has been used to encapsulate EO components 
with and without other ingredients such as zein and lecithin [12–14]. Thy-
mol nanoemulsified by NaCas showed a significant improvement of anti-lis-
terial activity in milk with different fat contents when compared to free thy-
mol [14]. However, much is unknown about the biophysical properties of EO 
components after nanoencapsulation.  
The first objective of this work was to characterize physicochemical and 
antimicrobial properties of nanoemulsions prepared with eugenol and Na-
Cas. Eugenol was chosen as a model EO component because of extensive 
research on its antimicrobial activities and the proposed antimicrobial mech-
anisms [1, 15]. Eugenol is a major component of clove oil and has a higher 
antibacterial activity than many other phenolic EO compounds or phenol 
esters such as carvacrol and basil methyl chavicol [1]. Additionally, proper-
ties of eugenol after nanoencapsulation by NaCas are unclear. The second 
objective was to evaluate biophysical changes of bacteria to understand im-
pacts of nanoencapsulation on antimicrobial mechanisms of eugenol against 
both Gram-negative Escherichia coli O157:H7 ATCC 43895 and Salmonella 
Enteritidis, and Gram-positive Listeria monocytogenes Scott A. 
Materials and Methods 
Chemicals 
NaCas was a product from American Casein Co. (Burlington, NJ, USA). 
Eugenol was purchased from Sigma-Aldrich Corp. (St Louis, MO, USA). 
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High-performance liquid chromatography (HPLC) grade water and metha-
nol (>99% purity) were procured from Fisher Scientific (Pittsburgh, PA, USA). 
Other chemicals were from either Sigma-Aldrich or Fisher Scientific. 
Preparation of Nanoemulsions 
NaCas was hydrated at 20.0 mg/mL in deionized water overnight at room 
temperature (RT, 21 °C), and the dispersion pH was measured to be 6.8. Dif-
ferent amounts of eugenol were mixed with the NaCas solution. The mix-
tures were then homogenized at 8000 rpm for 3 min using a Cyclone I.Q.2 
microprocessor homogenizer (VirTis Co., Gardiner, NY, USA). 
Determination of Encapsulation Efficiency (EE) 
Each emulsion sample was centrifuged at 6000 g for 5 min to remove free 
eugenol and large oil droplets (Minispin plus, Eppendorff, Hamburg, Ger-
many). The supernatant was diluted 100 times in deionized water and filtered 
through a 0.45 μm polyvinyl difluoride (PVDF) syringe membrane to obtain 
the permeate for HPLC. The reversed-phase HPLC analysis was performed 
with an Agilent Zorbax Eclipse Plus C18 column (5 μm; 150 mm by 4.6 mm; 
Agilent, Palo Alto, CA) and a 1200 series HPLC system (Agilent Technologies, 
Waldbronn, Germany). The sample injection volume was 10 μL, and the de-
tector wavelength was 274 nm. A binary solvent mixture of water and meth-
anol was used at a linear gradient from 20% to 80% methanol within 20 min 
for elution [16]. The flow rate was 0.5 mL/min, and the column chamber was 
controlled at 25 °C. A standard curve was prepared using standard solutions 
with eugenol dissolved at 0.010–1.0 mg/ mL in methanol to determine the 
amount of eugenol dispersed in unknown samples. 
Because eugenol has a water-solubility of ca. 1.35 mg/mL at 21 °C [16], 
the amount of eugenol dissolved in water was quantified. Excessive euge-
nol (10.0 mg/mL) was added into water and stirred using a stir plate at RT 
for at least 24 h, and then the oil content in the water phase was measured 
using HPLC after dilution and filtration as described above. The EE was then 
calculated using the following equation: 
EE% = 
Dispersed eugenol – Dissolved eugenol   × 100              (1)
                              Total eugenol – Dissolved eugenol 
Dimension and Stability of Eugenol Droplets at Different pHs 
The hydrodynamic diameter (Dh) was measured using a Delsa™ Nano-Zeta 
Potential and Submicron Particle Size Analyzer (Beckman Coulter, Inc., Brea, 
CA). The scattering angle was fixed at 165°. The emulsions were diluted 20 
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times using 10 mM phosphate buffered saline (PBS) adjusted to pH 5.0–9.0 
with 1.0 M HCl or NaOH. The stability of eugenol emulsions at various pHs 
was evaluated by measuring Dh after storage at RT for 1, 7, and 30 days. 
Three replicates were tested at each pH. 
Atomic Force Microscopy (AFM) 
Eugenol emulsions were diluted to a NaCas concentration of ca. 10 ppm in 
deionized water. Eight microliter of each sample was deposited and air-dried 
for 4 h on freshly cleaved mica sheets before imaging using a Multimode 
Nanoscope VIII microscope (FESPA, Bruker Corp., Santa Barbara, CA) with a 
rectangular cantilever having an aluminum reflective coating on the back-
side. The cantilever had a quoted force constant of 2.80 N/m and was op-
erated in the tapping mode. The topographical images were generated at 
a scanning speed of 1 Hz. Mean diameter of the particles was determined 
from the instrument software by taking averages from at least 5 images. 
Zeta (ζ)-Potential Measurement 
The ζ-potential of NaCas solution and eugenol emulsions was measured 
using a Zetasizer Nano ZS90 instrument (Malvern Instruments, Worcester-
shire, UK). Samples were diluted 10 times to 2.0 mg/mL NaCas in PBS and 
adjusted to pH 2.0– 9.0 with 1.0 M HCl or NaOH. The ζ-potential of each 
sample was measured at RT for three times. 
Determination of Antimicrobial Activity 
Bacterial Strain and Culture Preparation 
Stock cultures of L. monocytogenes Scott A, E. coli O157:H7 strain ATCC 
43895, and S. Enteritidis were obtained from the Department of Food Sci-
ence at the University of Tennessee (Knoxville, TN, USA). Bacteria were stored 
at −20 °C in glycerol and transferred at least 2 times in tryptic soy broth 
(TSB) and grown at 32 °C for L. monocytogenes and 37 °C for E. coli O157:H7 
and Salmonella with an interval of 24 h prior to use. Experiments were con-
ducted for at least two repetitions using independent cultures, each tested 
in duplicate. 
Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Con-
centration (MBC) 
A free eugenol stock solution was prepared by dissolving 2.0 g eugenol 
in 10.0 mL 50.0% v/v aqueous ethanol followed by diluting for 10 times in 
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distilled water to 20.0 mg/mL eugenol, corresponding to 5% v/v ethanol. The 
stock solution was further diluted in TSB to eugenol concentrations of 0.20, 
0.40, 0.60, 0.80, 1.0, 1.2, 1.5, 2.0, 2.5, and 3.0 mg/mL as working solutions. 
The emulsion with 38.5 mg/mL eugenol and 20.0 mg/mL NaCas was also 
diluted in TSB to corresponding eugenol concentrations as working sam-
ples. The bacterial culture was diluted to about 106 CFU/mL in TSB, and 120 
μL of the diluted culture was added into wells of a 96-well microtiter plate. 
Each well was then added with 120 μL of TSB or an antimicrobial sample. The 
plates were then incubated at 32 °C for L. monocytogenes or 37 °C for E. coli 
O157:H7 and Salmonella for 24 h. The absorbance at 630 nm of each well 
was measured before and after 24-h incubation (ΔAbs630) with a microtiter 
plate reader (Titertek Multiscan MC, Labsystems, Helsinki, Finland). The MIC 
was defined as the lowest eugenol concentration corresponding to ΔAbs630 
smaller than 0.05. To determine MBC, 10 μL mixture from the negative wells 
(i.e., ΔAbs630<0.05) was spread on tryptic soy agar (TSA) plates and incubated 
for 24 h at 32 °C for L. monocytogenes or 37 °C for E. coli O157:H7 and Sal-
monella. MBC was determined as the lowest eugenol concentration corre-
sponding to no detectable colonies after incubation. 
Growth Kinetics in TSB 
To study growth kinetics of bacteria in TSB, the bacterial culture was mixed 
with different amounts of free or encapsulated eugenol working samples 
prepared as in the previous section at an overall population of ca. 106 CFU/
mL and an eugenol content corresponding to MIC or one-half of MIC. The 
mixtures were incubated at 32 °C for L. monocytogenes or 37 °C for E. coli 
O157:H7 and Salmonella. After incubation for 0, 4, 8, 24, and 48 h, the cul-
tures were diluted in 0.1% peptone serially, and 0.10 mL of the diluted mix-
ture was spread on TSA plates. The TSA plates were incubated for 24 h at 
32 °C for L. monocytogenes or 37 °C for E. coli O157:H7 and Salmonella be-
fore counting the number of colonies. 
Biophysical Properties of Bacteria after Eugenol Treatment 
The emulsion prepared with an overall eugenol concentration of 38.5 mg/
mL was used to study differences in the following biophysical properties 
of bacteria before and after treatment, in comparison to free eugenol. Free 
eugenol prepared at 20.0% v/v in 50% aqueous ethanol and the emulsion 
were diluted to different concentrations with TSB for scanning electron mi-
croscopy (SEM) or PBS for the other two assays. Where applicable, the pos-
itive control of an emulsion was the solution with a same amount of NaCas, 
while that of free eugenol was the same concentration of aqueous ethanol. 
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Scanning Electron Microscopy 
Bacteria after treatment by 2.0 mg/mL free or encapsulated eugenol at RT 
for 1 h were fixed in 3% glutaraldehyde in 0.1 M sodium cacodylate buf-
fer for 1 h at RT. After rinsing in the buffer for 3 times, samples were post-
fixed in 2% osmium tetroxide. The samples after rinsing were dehydrated 
through a graded ethanol series from 25% to 100%. The structures of sam-
ples were imaged using a model LEO 1525 microscope (LEO Electron Mi-
croscopy, Oberkochen, Germany). 
Membrane Permeability Measured with the Crystal Violet Assay 
Alteration in membrane permeability after antimicrobial treatments was 
studied using the crystal violet assay [15]. E. coli O157:H7, Salmonella, and 
L. monocytogenes in TSB were harvested at 4300 g for 4 min, washed twice 
with 0.1 M PBS (pH 7.4), and re-suspended in PBS. An antimicrobial sample 
with 1.8 mg/mL eugenol or an antimicrobial control was added to the cell 
suspensions and incubated at 37 °C or 32 °C for 1 h. After incubation, cells 
were harvested at 6700 g for 5 min and resuspended in 2 mL PBS contain-
ing 10 μg/mL of crystal violet. After incubating for another 15 min, the sus-
pensions were centrifuged at 13,400 g for 15 min and the absorbance of the 
cell free supernatant was measured at 590 nm (Abscell). The absorbance at 
590 nm of the PBS with 10 μg/mL crystal violet (AbsPBS) was also measured. 
The percentage of crystal violet uptake in a cell suspension was calculated 
using the following equation. 
Uptake (%) = (1− Abscell ) × 100                                             (2)                                                 AbsPBS
Estimation of Intra- and Extracellular Adenosine Triphosphate (ATP) 
Contents 
The intracellular and extracellular ATP concentrations were measured ac-
cording to a literature method [17]. The suspensions containing ~9 log CFU/
mL bacteria were centrifuged at 4300 g for 2 min to harvest cells. After re-
suspension in 0.1 M PBS (pH 7.4), 1 mL suspension with ca. ~8 log CFU/mL 
bacteria was treated with 30, 60 or 100 μL of a sample containing 20.0 mg/
mL free or encapsulated eugenol. After incubation for 20 min at RT, the bac-
teria were harvested at 4300 g. The supernatants with extracellular matter 
were collected and immediately moved to an ice bath before further anal-
ysis. After decanting the supernatant, cells were resuspended in 1.0 mL of 
0.5% w/v trichloroacetic acid buffer and then centrifuged immediately at 
13,400 g for 10 min. The supernatant containing intracellular materials was 
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neutralized with 4-fold volume of 0.1 M PBS (pH 7.4) and then stored in an 
ice bath to prevent ATP loss. 
The Enliten™ ATP Assay system with a bioluminescence detection kit (Pro-
mega, Madison, WI) was used for ATP measurement following the manual. 
Briefly, the rL/L reagent was rehydrated in the reconstitution buffer and in-
cubated at RT for 1 h before use. Ten microliter of a sample and 100 μL of 
the reagent solution were added into wells of a 96-well microtiter plate, and 
the luminescence values were measured with a model Synergy HT reader 
(BioTek, Winooski, VT). An ATP standard curve was established using the 
ATP standard and ATP-free water from the kit supplier to determine the in-
tra- and extracellular ATP concentrations. Experiments were conducted for 
three repetitions with independent cultures. 
Statistical Analysis 
All experiments were carried out at least in duplicate. All results were re-
ported for the mean ± standard deviation (SD) of replicates. The one-way 
analysis of variance of treatments was performed at a significance level (P) 
of 0.05 using the least significant difference method assisted with SPSS 16.0 
statistical analysis system (SPSS Inc., Chicago, IL, USA). 
Results 
Encapsulation Properties and Droplet Dimensions of Eugenol 
Emulsions 
The properties of 20.0 mg/mL NaCas encapsulating eugenol at the studied 
conditions are shown in Table 1. The amount of eugenol dispersed in emul-
sions was the highest (38.0 mg/mL) when eugenol was used at an overall 
concentration of 74.1 mg/mL. Therefore, emulsifying eugenol with NaCas 
greatly improved the amount of eugenol dispersed in water. The amount of 
eugenol dissolved in water at RT was quantified to be 1.5 mg/mL. The EE% 
after calibration of the dissolved eugenol (eq. 1) decreased when a higher 
amount of eugenol was used in preparation. No noticeable phase separa-
tion was observed for emulsions prepared with an overall eugenol concen-
tration of 38.5 mg/mL and lower (supplementary Fig. S1, following the Ref-
erences), and these emulsions had an EE% of 86% or higher (Table 1). Phase 
separation observed for emulsions with a total eugenol concentration of 74.1 
mg/mL and higher corresponded to low EE%. Therefore, only emulsions with 
an overall eugenol content of 38.5 mg/mL and lower were studied further. 
Emulsions prepared with a higher amount of eugenol had a significantly 
smaller Dh (Table 2). Because homogenization itself had no significant impact 
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on the Dh of NaCas, encapsulation of eugenol caused the reduction of Dh. 
The reduced dimension of NaCas after encapsulating eugenol was also ob-
served in AFM (Fig. 1), which showed more uniform and spherical particles 
after emulsification. The average particle diameter from AFM decreased 
from 123.2 nm of NaCas to 106.3 and 84.5 nm for emulsions prepared with 
5.0 and 38.5 mg/mL eugenol, respectively. The emulsion prepared with 38.5 
mg/mL eugenol was used in following studies. 
Stability of Eugenol Emulsions at Different pHs 
The pH stability of emulsions diluted to 1.9 mg/mL eugenol is shown in Fig. 
2. The diluted emulsions were transparent at a pH of 5.0 and above, and 
those at alkaline pH appeared yellow. Precipitation was observed when pH 
was lower than 5.0. To evaluate the storage stability of emulsions at pH 5.0–
9.0, Dh was measured after storage at RT for 1, 7, and 30 days (Fig. 3). There 
was no significant increase of droplet size in the first 7 days (P > 0.05), with 
Dh ranging from 100 to 125 nm. Except for the pH 5.0 treatment showing 
some precipitation, Dh increased significantly (P < 0.05) after 30-day stor-
age. Nevertheless, the Dh of the emulsions at pH 5.0–9.0 before and after 
storage was still smaller than that of NaCas at pH 7.0 without eugenol (~150 
nm, Table 2). 
The ζ-potential of NaCas with and without eugenol at pH 2.0–9.0 is pre-
sented in Fig. 4. The ζ-potential of NaCas decreased from 23.7 to −35.0 mV 
when pH increased from 3.0 to 9.0, and a ζ-potential close to 0 mV was 
observed at around pH 4.5. After encapsulating eugenol, a more negative 
ζ-potential with a magnitude above 30 mV was observed at pH 5 and above. 
MIC and MBC of Eugenol 
MICs and MBCs of free (pre-dissolved in ethanol) and emulsified eugenol 
against Gram-positive L. monocytogenes and Gram-negative E. coli O157:H7 
and Salmonella are presented in Table 3. The MICs of both free and encap-
sulated eugenol were 1.2, 0.6, and 0.6 mg/mL when tested against L. mono-
cytogenes, E. coli O157:H7, and Salmonella, respectively. The encapsulation 
also did not show a significant effect on the MBCs against L. monocytogenes 
(2.0 mg/mL) or E. coli O157:H7 (0.8 mg/mL), while the encapsulated euge-
nol had a slightly lower MBC than free eugenol (0.8 vs 1.0 mg/ mL) against 
Salmonella. 
Growth Kinetics of Bacteria in TSB 
The antimicrobial activities of free and encapsulated eugenol were also com-
pared for the growth kinetics shown in Fig. 5. The growth curves of controls 
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with and without NaCas were similar. When free and encapsulated eugenol 
was studied at one-half of MIC, the growth of all three bacteria was delayed 
but not inhibited. At an eugenol concentration equivalent to MIC, the growth 
kinetics was different for each bacterium. An initial reduction of L. mono-
cytogenes up to 4 h was observed for both free and encapsulated eugenol 
treatments, followed by a significant recovery (Fig. 5a). For E. coli O157:H7 
(Fig. 5b), free eugenol showed a reduction by ~1 log CFU/ mL after 8 h, fol-
lowed by growth to the inoculation level after 24 h, which contrasted with a 
reduction of ca. 3 log CFU/mL in 8 h by the same concentration of encapsu-
lated eugenol followed by insignificant changes after 24 and 48 h. Eugenol 
was the most effective against Salmonella, showing a gradual reduction to 
the detection limit in 24 h followed by a minor recovery after 48 h (Fig. 5c). 
Changes of Bacterial Morphology after Eugenol Treatments 
Figure 6 shows the SEM micrographs of bacteria after treatment by 2.0 mg/
mL free or encapsulated eugenol. E. coli O157:H7 and Salmonella cells not 
treated by eugenol showed an irregular and striated surface characteristic 
of Gram-negative bacteria, while L. monocytogenes exhibited a smooth sur-
face. For the two Gram-negative bacteria, both eugenol treatments induced 
the damage of cell structures, showing the roughening and collapse of rod-
like morphology. L. monocytogenes cells after free eugenol treatment either 
showed unnoticeable changes in the shape or surface smoothness or were 
completely destroyed (Fig. 6a2). Based on estimations from at least 5 SEM 
micrographs, about 39% and 80% L. monocytogenes maintained the rod-like 
morphology after treatment by free and encapsulated eugenol, respectively. 
Intra- and Extracellular ATP Concentrations 
The intra- and extracellular ATP concentrations of the three bacteria after 
being treated with free and encapsulated eugenol were measured to bet-
ter understand the potential antibacterial mechanism (Fig. 7). Controls with-
out antimicrobial treatments showed intra- and extracellular ATP levels of 
0.036 and 0.0039 nmol for L. monocytogenes, 0.045 and 0.0048 nmol for E. 
coli O157:H7, and 0.031 and 0.0024 nmol for Salmonella, respectively. Na-
Cas alone did not show any significant effect on either intra- or extracellu-
lar ATP concentrations of all three bacteria (data not shown). 
When treated by free eugenol up to 2.0 mg/mL, no significant differ-
ence in the extracellular ATP of any of the three bacteria was observed (P > 
0.05). No decrease in the intracellular ATP concentration was observed at 
0.6–2.0 mg/mL of free eugenol for L. monocytogenes, 0.6 mg/mL for E. coli 
O157:H7, and 0.6–1.2 mg/mL for Salmonella. In contrast, a significant reduc-
tion of intracellular ATP concentration was observed for E. coli O157:H7 and 
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Salmonella treated by 0.6 mg/mL and more encapsulated eugenol, as well 
as L. monocytogenes treated with 1.2 and 2.0 mg/ml encapsulated eugenol 
(P < 0.05). A significant reduction of intracellular ATP of bacteria treated with 
a sufficiently high amount of encapsulated eugenol corresponded to a sig-
nificant increase in extracellular ATP. 
The Uptake of Crystal Violet by Bacteria after Eugenol Treatments 
Figure 8 shows the uptake of crystal violet after treatments with and with-
out 1.8 mg/mL free or encapsulated eugenol. NaCas showed no obvious 
effect on the uptake of crystal violet by the bacteria. All bacteria showed 
an increased uptake of crystal violet after treatment with free or encapsu-
lated eugenol. The crystal violet uptake by L. monocytogenes after free eu-
genol treatment was higher than the control, while the increase in crystal vi-
olet uptake of the encapsulated eugenol treatment was not significant. The 
crystal violet uptake by E. coli O157:H7 after treatment with encapsulated 
eugenol was not significantly different from that of free eugenol treatment 
(P > 0.05). Lastly, the crystal violet uptake by Salmonella after treatment by 
encapsulated eugenol was significantly higher than the free eugenol treat-
ment (P < 0.05). 
Discussion 
Physical Properties of Eugenol Nanoemulsions 
Emulsions with droplets smaller than 125 nm (Table 2; Fig. 1) and overall 
good kinetic stability (Fig. 3) were prepared with 20.0 mg/mL NaCas and 
up to 38.5 mg/mL eugenol (Table 1), and the EE% was higher than 86% (Ta-
ble 1). These characteristics were better than 50 mg/mL NaCas emulsifying 
up to 10 mg/mL thymol as stable dispersions [14]. NaCas consists of mix-
tures of αs1-, αs2-, β-, and κ-caseins at proportions of approximately 4:1:4:1 
that are all known to be surface active, with β-casein being recognized for 
the greatest contributor of emulsifying properties [18]. Thymol has a melt-
ing point of about 50 °C [19] and a water solubility of 0.48 mg/mL at 21 °C 
[16], whereas eugenol is a liquid and has a water-solubility of 1.50 mg/mL at 
21 °C measured in the present study, with the latter agreeing with the pre-
viously reported solubility of 1.35 mg/mL [16]. The higher hydrophilicity of 
eugenol than thymol results in a lower oil/water interfacial tension and the 
higher fluidity (liquid vs. solid) lowers the viscosity of the dispersed phase 
during emulsification, which favor emulsion formation during shear homog-
enization. Additionally, NaCas is hydrophilic and is expected to have a hy-
drophile-lipophile balance closer to eugenol than thymol. These factors can 
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contribute to the better capacity of NaCas emulsifying eugenol in the pres-
ent study than that of thymol [14]. 
A smaller dimension of emulsions with a higher content of eugenol was 
observed both in dynamic light scattering (Table 2) and AFM (Fig. 1). The 
observation is in contrast with the expectation of larger droplets at a higher 
oil concentration because of the reduced surfactant-to-oil ratio during ho-
mogenization [20], as shown for oregano EO emulsified into an aqueous 
phase containing chitosan-tripolyphosphate nanoparticles and Tween 80 
[21]. NaCas is composed of structures with a dimension of 10–20 nm and 
some indicate loosely associated proteins when observed in transmission 
electron microscopy [22]. Caseins are also known to be intrinsically disor-
dered proteins with little higher order structures [23]. These characteristics of 
NaCas can contribute to a dimension of >100 nm measured in DLS (Table 2) 
and AFM, after drying on a mica sheet (Fig. 1). As previously discussed [14], 
emulsification of eugenol and hydrophobic attraction by eugenol improve 
the compactness of particulate structures containing NaCas, which reduces 
the dimension measured in DLS and AFM. 
Caseins have an isoelectric point at pH 4.6 [10], and dispersions with poor 
stability below pH 5.0 (Fig. 2) are characteristics of caseins. The yellow color 
of emulsions at alkaline pH can be attributed to the increased water solu-
bility of eugenol due to deprotonation of hydroxyl groups [10, 22]. Above 
pH 5.0, emulsions have a zeta-potential magnitude of >30 mV which can 
typically provide repulsive electrostatic interactions strong enough to sta-
bilize colloidal particles against aggregation [24, 25]. NaCas is also known 
to provide steric stabilization when present at the surface of colloidal par-
ticles [25]. Therefore, eugenol emulsions had insignificant changes in Dh at 
pH 5.0–9.0 within 7 days at RT (Fig. 3). As discussed previously, eugenol is 
slightly soluble in water, and the solubility is higher at a higher pH. This can 
cause Ostwald ripening that results from the higher solubility of eugenol in 
smaller droplets, which causes the dissolving out of eugenol to join bigger 
droplets with a lower Laplace pressure [25]. The growth of droplets, more 
apparent at a higher pH, was therefore evident after storage for 30 days 
(Fig. 3). Changes in emulsion droplet size after 30-day storage may have 
accounted for some precipitation at pH 5.0, since eugenol is slightly denser 
than water at RT [19]. 
Antimicrobial Properties of Eugenol Nanoemulsion 
The MICs of free eugenol (Table 3) against L. monocytogenes (1.2 mg/mL), E. 
coli O157:H7 (0.6 mg/mL), and Salmonella (0.6 mg/mL) agreed with a pre-
vious study [1]. The MICs of both free and encapsulated eugenol at 32 or 
37 °C are similar (Table 3) and are all lower than the water solubility of 1.5 
mg/mL at 21 °C. The encapsulated eugenol partitions between droplets, the 
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continuous aqueous phase, and bacteria due to concentration gradients. This 
indicates no negative impact of NaCas, which can bind with eugenol, on an-
timicrobial activity of eugenol. Similar explanation can be made for MBCs of 
free and encapsulated eugenol. When tested for growth kinetics at eugenol 
levels corresponding to the MICs, Gram-negative E. coli O157:H7 and Sal-
monella were inhibited to a greater extent by eugenol than Gram-positive 
L. monocytogenes (Fig. 5), and significant differences between free eugenol 
and emulsion treatments were only observed for E. coli O157:H7 at 37 °C. 
The former observation agrees with the lower MIC of Gram-negative than 
Gram-positive bacteria (Table 3). The latter observation can result from dif-
ferent membrane structures between E. coli O157:H7 and Salmonella, since 
disrupting bacterial membranes is a major mechanism of the antibacterial 
activity of eugenol [26], further discussed below. 
Biophysical Properties of Bacteria Treated by Free and Nanoemulsified 
Eugenol 
Eugenol is a multi-target antimicrobial agent, with the primary mechanism 
being the disruption of cell membrane through non-specific binding with 
lipophilic constituents of the membrane [27, 28] and the secondary mecha-
nism being inhibitions of enzymes involved in the biosynthetic pathway [29]. 
The latter was studied for the inhibition of 1-deoxy-D-xylulose 5-phosphate 
reductoisomerase (DXR) [30], a key enzyme of the methylerythritol phos-
phate pathway [29]. Eugenol had a much higher activity than carvacrol, thy-
mol, and linalool inhibiting DXR and the mode of inhibition was observed to 
be competitive, indicating the specificity of binding between eugenol and 
DXR [29, 30]. These mechanisms may be used to understand impact of na-
noencapsulation on eugenol-bacterium interactions based on the measured 
biophysical properties, although variations in eugenol concentration, bac-
terial population, and treatment temperature and duration adopted for dif-
ferent assays may not allow direct correlation of all sets of data. 
Compared to Gram-negative bacteria with an envelope consisting of an 
outer membrane containing lipopolysaccharides, a peptidoglycan cell wall, 
and an inner cytoplasmic membrane, Gram-positive bacteria lack of the 
outer membrane, making it easier to change structures after interacting 
with antimicrobials [31, 32]. The structural differences of Gram-negative 
and Gram-positive bacteria agree with a significant portion of collapsed L. 
monocytogenes cells while only morphological changes of E. coli O157:H7 
and Salmonella after treatment by same amounts of eugenol (Fig. 6). When 
compared with free eugenol, eugenol in the emulsion partitions with Na-
Cas and bacteria, which reduces the availability of eugenol to interact with 
bacteria within a limited duration. This physical phenomenon agrees with a 
smaller percentage of L. monocytogenes cell collapse after 1-h treatment by 
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the emulsion with 2 mg/mL eugenol than the same amount of free euge-
nol (39% vs. 80% based on SEM, Fig. 6). Whereas, no complete cell collapse 
was observed for E. coli O157:H7 and Salmonella treated by 2.0 mg/mL eu-
genol (Fig. 6), a level more than twice of their MBCs (Table 3). Therefore, cell 
death is not completely dependent on cell destruction. 
Changes in bacterial morphology in Fig. 6 however are not in agreement 
with the crystal violet uptake% by bacteria treated with 1.8 mg/mL encapsu-
lated or free eugenol at 32 or 37 °C for 1 h (Fig. 8). The encapsulated euge-
nol had similar crystal violet uptake% as free eugenol and the control treat-
ments without antimicrobials for L. monocytogenes and E. coli O157:H7 at 
the studied conditions (Fig. 8). In contrast, a significant increase of crystal 
uptake% was observed for Salmonella treated by 1.8 mg/mL encapsulated 
eugenol than free eugenol, both of which were higher than the controls (Fig. 
8). These observations are different from the lower crystal violet uptake% of 
the three bacteria treated by 0.2–0.9 mg/mL thyme oil nanoencapsulated 
by NaCas and lecithin than free thyme oil [33]. Crystal violet stains bacterial 
peptidoglycan, and an increased uptake of crystal violet can be correlated 
to an increase of non-specific permeability of cytoplasmic membrane [15]. 
At the assay conditions, peptidoglycan in cell debris of L. monocytogenes 
can also be available to staining by crystal violet, making the difference be-
tween encapsulated and free eugenol treatments insignificant. For the two 
Gram-negative bacteria, data in Fig. 8 indicate the increased permeability 
of cytoplasmic membrane after treating Salmonella with encapsulated eu-
genol than free eugenol, but the same is not true for E. coli O157:H7. This 
is opposite with the growth curves in Fig. 5 showing the enhanced inhibi-
tion of E. coli O157:H7 after encapsulation of eugenol but insignificant dif-
ference in inhibiting Salmonella by free and encapsulated eugenol at the 
MIC. Therefore, crystal violet assay results did not provide a complete inter-
pretation of antimicrobial activities. 
The trend is consistent for the ATP data in Fig. 7 after treating bacteria 
for a short duration of 20 min at RT. The significant reduction of intracel-
lular ATP was observed at a lower concentration of encapsulated eugenol 
than free eugenol for all three bacteria. The increase of extracellular ATP of 
the three bacteria was significant for the emulsion treatment at a range of 
0–2.0 mg/mL eugenol, while for free eugenol treatments, the increase was 
significant only for E. coli O157:H7. A depletion of intracellular ATP may be 
attributed to the release or loss of ATP from cells, hydrolysis in cells, and/or 
inhibition of membrane transport [34]. An increase of extracellular ATP con-
centration is due to the loss of intracellular ATP, which can be attributed to 
an increased degree of cytoplasmic membrane disruption [17]. The data in 
Fig. 7 suggest the increased permeability of emulsified eugenol than free eu-
genol after short-time interaction. An increase in the extracellular ATP con-
tent of both Gram-negative Salmonella Enteritidis and Gram-positive Bacillus 
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cereus treated by linolenic acid was also reported after addition of a surfac-
tant, glycerol laurate or glycerol myristate, which was correlated to the en-
hanced antimicrobial activity of the combination [35]. Surfactants with ap-
propriate physicochemical properties can accumulate in the membrane lipid 
bilayer to cause the redistribution of membrane protein and lipids, which in-
fluences the membrane function [35–37]. The adsorption of surfactants on 
bacterial membrane can facilitate the accumulation of antimicrobials on cell 
surface and the subsequent penetration into cells, which can be correlated 
to the observed enhancement of antimicrobial activities [35]. In addition, 
ionic residues of peripheral proteins can enable the binding with a mem-
brane surface by electrostatic interactions, while aliphatic and aromatic res-
idues of these proteins can result in the subsequent membrane penetration 
[38]. Therefore, the known membrane binding activities of caseins [39, 40] 
may have resulted in the increased extracellular ATP and decreased intra-
cellular ATP of bacteria treated by a sufficiently high content of emulsified 
eugenol (Fig. 7). The observation of higher extracellular ATP content of Sal-
monella treated by encapsulated eugenol than free eugenol (Fig. 7) was in 
accordance with the relatively higher crystal violet uptake (Fig. 8). However, 
the same correlation of ATP data in Fig. 7 and crystal violet uptake data in 
Fig. 8 was not observed for E. coli O157:H7. 
The data in the present study may be interpreted by also considering 
other known knowledge in the literature. When subjected to a stress such 
as antimicrobials, it is well-known that bacteria can change the composition 
and biophysical properties of membranes so as to adapt to survive through 
a stress [41, 42]. Initially, NaCas facilitates the accumulation of eugenol at 
the membrane and permeation into bacteria (Fig. 7) [43]. However, when 
given time, the adaptation of membrane can be different for each bacterium. 
L. monocytogenes, although having a significant portion of cell disruption 
by 2.0 mg/mL eugenol (Fig. 6), can adapt and recover to result in no signif-
icant difference in growth curves for free and encapsulated eugenol treat-
ments at MICs (Fig. 5). For the two Gram-negative bacteria, E. coli O157:H7 
may not be as effective as Salmonella adapting to the antimicrobial stress, 
resulting in a greater reduction by encapsulated eugenol than free eugenol 
at a level of MIC in the growth kinetics assay (Fig. 5). This speculation how-
ever requires future work, for example using small angel neutron scattering 
to study biophysical structures of model membranes after interacting with 
free and encapsulated eugenol [44]. 
Conclusions 
In summary, up to 38.5 mg/mL eugenol was emulsified by 20.0 mg/mL Na-
Cas using shear homogenization. Encapsulation of eugenol decreased the 
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dimension of NaCas and increased the magnitude of negative zeta poten-
tial above pH 5.0 that corresponded to stable emulsion droplet dimensions 
during storage up to 7 days at 21 °C. The encapsulated eugenol showed 
similar MICs and MBCs against L. monocytogenes, E. coli O157:H7 and Sal-
monella as eugenol pre-dissolved in ethanol. The encapsulated eugenol ap-
plied at MICs was more effective against the growth of E. coli O157:H7 than 
free eugenol at 37 °C in 48 h, but differences were insignificant for L. mono-
cytogenes and Salmonella at 32 and 37 °C, respectively. After interaction at 
21 °C for 20 min, all three bacteria showed the increased accumulation and 
permeation of encapsulated eugenol than free eugenol based on changes 
in intra- and extracellular ATP contents. However, the same trend was not 
observed based on examination of morphology and uptake of crystal vio-
let. The current study points to the future direction on examining changes 
of membrane composition and biophysical properties to better understand 
mechanisms of nanoencapsulated eugenol interacting with bacteria and the 
correlation to antibacterial activities. The study nevertheless showed the ex-
cellent properties of NaCas emulsifying eugenol to prepare stable emulsions 
as intervention systems.   
Tables 1–3, Figures 1–8, & Supplementary Figure S1,  
Acknowledgments, and References follow.
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Table 1. Properties of 20.0 mg/mL NaCas emulsifying eugenol 
Overall eugenol  Dispersed eugenol  Encapsulation  
content (mg/mL)  (mg/mL)  efficiency (%) 
5.0  5.0 ± 0.3e  98.9 ± 6.8 
9.9  9.4 ± 0.1d  93.4 ± 0.6 
19.6  17.2 ± 0.1c  86.7 ± 0.7 
38.5  33.4 ± 0.5b  86.2 ± 1.1 
74.1  38.0 ± 1.1a  50.3 ± 1.5 
137.9 36.3 ± 0.4a  25.5 ± 0.3 
Numbers are mean ± standard deviation from triplicate samples. Different super-
script letters indicate differences in the mean of the same parameter (P < 0.05). 
Table 2. Hydrodynamic diameter (Dh) of dispersions with various amounts of euge-
nol emulsified by 20.0 mg/mL NaCas at pH 7.0 
Overall eugenol content (mg/mL)  Dh (nm) 
0  153.8 ± 3.1 a 
0#  146.3 ± 3.0 a 
5.0  124.6 ± 2.7 b 
9.9  117.4 ± 0.9 b 
19.6  110.3 ± 1.9 bc 
38.5  104.7 ± 2.0 c 
Numbers are mean ± standard deviation from triplicate samples. Different super-
script letters indicate differences in the mean (P < 0.05). 
# The sample was also homogenized at eugenol emulsion preparation conditions. 
Table 3. Minimum inhibitory concentration (MIC) and minimum bactericidal con-
centration (MBC) of free (pre-dissolved in ethanol) or encapsulated eugenol against 
three bacteria 
Bacteria                          MIC (mg/mL)                        MBC (mg/mL) 
                                       Free    Encapsulated             Free       Encapsulated 
L. monocytogenes   1.2  1.2  2.0  2.0  
     Scott A
E. coli O157:H7   0.6  0.6  0.8  0.8  
     ATCC 43895
Salmonella Enteritidis  0.6  0.6  1.0  0.8 
NaCas showed no inhibition.   
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Fig. 1. AFM topography images of NaCas (a) and dispersions with 5mg/mL (b) or 
38.5mg/mL (C) eugenol emulsified by 20.0 mg/mL NaCas at pH 7.0. Dispersions 
were diluted to ca. 0.01 mg/mL NaCas before drying for AFM. The scale on the right 
shows particle height  
Fig. 2. Appearance of the emulsion containing 38.5 mg/mL eugenol after 20-fold di-
lution in PBS adjusted to pH 2.5, 3.0, 4.0, 5.0, 6.0, 7.0, 8.0 and 9.0 (from left to right) 
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Fig. 3. Average hydrodynamic diameters of nanoemulsions with 1.9 mg/ mL eu-
genol after adjusting pH to 5.0–9.0 and storing at 21 °C for 1, 7, and 30 days. The 
emulsion was prepared with 38.5 mg/mL eugenol and diluted with PBS. Error bars 
are standard deviations (n = 3)  
Fig. 4. Zeta-potential of 10-fold diluted dispersions with 20.0 mg/mL NaCas and the 
emulsion prepared with 38.5 mg/mL eugenol and 20.0 mg/mL NaCas. The samples 
were adjusted to pH 2.0–9.0 and diluted 10 times in PBS adjusted to the same pH 
before measurements. Error bars are standard deviations (n = 3)  
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Fig. 5. The growth curves of 
L. monocytogenes at 32 °C 
(a), E. coli O157:H7 at 37 °C 
(b) and Salmonella at 37 °C 
(c) in TSB treated by 
nothing (negative control, 
black filled square), 0.6 
mg/mL NaCas (black open 
square), free eugenol (pre-
dissolved in 5% ethanol) at 
MIC (blue filled circle) and 
one-half of MIC (red filled 
triangle), or encapsulated 
eugenol at MIC (blue open 
circle) and one-half of 
MIC (red open triangle). 
Detection limit is 1.0 log 
CFU/mL. Error bars are 
standard deviations (n = 3) 
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Fig. 6. SEM micrographs of L. monocytogenes (a), E. coli O157:H7 (b) and Salmo-
nella (c) received no treatment (1) or after treatment with 2.0 mg/mL free euge-
nol pre-dissolved in ethanol (2) or 2.0 mg/mL eugenol encapsulated by NaCas (3) 
for 1 h at 21 °C  
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Fig. 7. Intra- (black square) and extracellular (red circle) ATP concentrations of L. 
monocytogenes (a, b), E. coli O157:H7 (c, d), and Salmonella (e, f) treated by differ-
ent amounts of free (a, c, e) or encapsulated (b, d, f) eugenol at 21 °C for 20 min. 
Error bars are standard deviations (n = 3). Different letters indicate significant dif-
ferences of treatments on the same curve  
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Fig. 8. The uptake% of crystal violet by L. monocytogenes at 32 °C (a), E. coli O157:H7 
at 37 °C (b), and Salmonella at 37 °C (c) after 1-h treatment by: (1) no additional 
compound; (2) 1.8 mg/mL NaCas; (3) 1.8 mg/mL eugenol pre-dissolved in 5% eth-
anol, and (4) 1.8 mg/mL encapsulated eugenol with 2.0 mg/mL NaCas. Error bars 
are standard deviations (n = 3). Different letters above bars indicate significant dif-
ferences in the mean of the same bacterium treatments   
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